Publications by authors named "Pascal Juillerat"

Claim this Profile
I
International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for Improvements.
María José Casanova, Javier P Gisbert, Aurelien Amiot, Hannah Gordon, Gionata Fiorino, Pascal Juillerat

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.
Aurélien Amiot, Anthony Buisson, Jean Marc Gornet, Mathurin Fumery, Lucine Vuitton, Pascal Juillerat

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease.
Marla C Dubinsky, Geert D'Haens, Olivier Dewit, Pascal Juillerat, Remo Panaccione

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational Survey.
Ana Catarina Bravo, Sara Godt Christensen, Mette Julsgaard, Iago Rodriguez-Lago, Lucía Exposito, Pascal Juillerat

United European Gastroenterol J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co-Design Approach With General Practitioners and Patients.
Kristie Rebecca Weir, Clémentine Tombez, Yvonne Mattmann, Sofia C Zambrano, Eliza Ferguson, Pascal Juillerat

Basic Clin Pharmacol Toxicol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.
Miguel Regueiro, Monika Fischer, Peter Bossuyt, Marijana Protic, Kristina Traxler, Pascal Juillerat

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care.
Angela Edith Schulthess-Lisibach, Renata Vidonscky Lüthold, Clémentine Tombez, Kristie Rebecca Weir, Martina Zangger, Pascal Juillerat

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial.
Luc Biedermann, Michael Doulberis, Philipp Schreiner, Ole Haagen Nielsen, Frans Olivier The, Pascal Juillerat

Nutrients· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone health in patients with inflammatory bowel disease.
Andrea S Kreienbuehl, Gerhard Rogler, Burri Emanuel, Luc Biedermann, Christian Meier, Pascal Juillerat

Swiss Med Wkly· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series.
Davide Giuseppe Ribaldone, Giulia Testa, Bram Verstockt, Tamas Molnar, Edoardo Savarino, Pascal Juillerat

J Crohns Colitis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.
Hannah Gordon, Johan Burisch, Pierre Ellul, Konstantinos Karmiris, Konstantinos Katsanos, Pascal Juillerat

J Crohns Colitis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.
Laura Rossier, Christoph Matter, Emanuel Burri, Tatiana Galperine, Petr Hrúz, Pascal Juillerat

Swiss Med Wkly· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning in Antibody Diagnostics for Inflammatory Bowel Disease Subtype Classification.
Christiane Sokollik, Aurélie Pahud de Mortanges, Alexander B Leichtle, Pascal Juillerat, Michael P Horn

Diagnostics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort study.
Brian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, Niklas Krupka, Luc Biedermann, Pascal Juillerat

Therap Adv Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Pauline Veyrard, Gauthier Pellet, David Laharie, Maria Nachury, Pascal Juillerat

Clin Gastroenterol Hepatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking microbial DNA enrichment protocols from human intestinal biopsies.
Dmitrij Marchukov, Jiaqi Li, Pascal Juillerat, Benjamin Misselwitz, Bahtiyar Yilmaz

Front Genet· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD.
Shaji Sebastian, Jonathan P Segal, Charlotte Hedin, Gianluca Pellino, Paulo Gustavo Kotze, Pascal Juillerat

J Crohns Colitis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.
Joana Torres, María Chaparro, Mette Julsgaard, Konstantinos Katsanos, Zuzana Zelinkova, Pascal Juillerat

J Crohns Colitis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
Maude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, Riad Sarraj, Eileen Benz, Pascal Juillerat

Eur J Gastroenterol Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L Pangan, Jesse Siffledeen, Pascal Juillerat

Lancet· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning biologics in the treatment of IBD: A practical guide
Pascal Juillerat, Maude Martinho Grueber, Roseline Ruetsch, Giulia Santi, Marianne Vuillèmoz

Curr Res Pharmacol Drug Discov· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vacuum-Sponge Therapy Placed through a Percutaneous Gastrostomy to Treat Spontaneous Duodenal Perforation.
Maude Martinho-Grueber, Ioannis Kapoglou, Eileen Benz, Yves Borbély, Pascal Juillerat

Case Rep Gastroenterol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie Long, Matthieu Allez, Pascal Juillerat

Lancet Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
Kathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, Jean-Benoît Rossel, Luc Biedermann, Pascal Juillerat

Therap Adv Gastroenterol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'.
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, Stephan Vavricka, Miguel Bettencourt

Adv Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis